Skip to main content
OpenTrials
Completed

NCT Number: NCT04037423

European Database on Catheter-directed Treatment of Pulmonary Embolism.

The main goals of EuroPE-CDT is to assess the currently applied catheter-directed treatment (CTD) techniques and strategies in pulmonary embolism (PE) patients and to determine the short term efficacy and safety of this invasive procedure.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Internal Medicine & Cardiology with the Centre for Management of Venous Thromboembolic Disease, Medical University of Warsaw

Warsaw, 02-005, Poland

About this study

This is a prospective (and retrospective, if required data are available), non-interventional, multicenter study. We intend to obtain data on basic patients characteristics, pulmonary embolism severity, catheter-directed treatment procedures and short term outcome. We are planning to include approximately 150-200 patients suitable for analysis by the end of 2020. Anonymized data of consecutive PE patients treated with CTD in European centers will be collected in the database.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • acute pulmonary embolism
  • catheter-directed embolectomy

Exclusion criteria

  • appropriate data not available

Treatment and study plan

Primary outcomes

  1. Survival

    Time frame: 30 days after the procedure

    Short-time follow-up

Secondary outcomes

  1. Complications

    Time frame: During hospitalisation (estimated 10 days)

    Any procedure-related complications, such as:

    • local hematoma,
    • hemoptysis,
    • pulmonary artery injury,
    • contrast-induced nephropathy,
    • renal replacement therapy.

Sponsors and collaborators

Lead sponsor

Medical University of Warsaw

Other

Registry information

Acronym: EuroPE-CDT

Important dates

Study start
2019
Primary completion
2021
Study completion
2022
First posted
Jul 30, 2019
Registry last updated
Aug 1, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.